Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT03845712
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-18
First Post:
2019-02-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency
Sponsor:
UCB BIOSCIENCES, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-19
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-06
First Submit QC Date:
None
Study First Post Date:
2019-02-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-16
Last Update Post Date:
2025-05-18
Last Update Post Date Type:
ACTUAL